Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Pin to quick picksNetscientific Share News (NSCI)

Share Price Information for Netscientific (NSCI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 63.00
Bid: 61.00
Ask: 65.00
Change: 0.00 (0.00%)
Spread: 4.00 (6.557%)
Open: 63.00
High: 63.00
Low: 63.00
Prev. Close: 63.00
NSCI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: NetScientific invests GBP1 million into Martlet Capital

Thu, 16th Sep 2021 18:04

NetScientific PLC - London-based investor in life sciences companies - Invests GBP1 million into Martlet Capital Ltd, which is looking to raise a total of GBP22 million over the next six months to fund the acquisition of a portfolio of minority interests in the Cambridge high-tech cluster.

Investment leads to initial equity interest of 6.8% in Martlet. Looking ahead, NetScientific expects to establish a follow-on funding vehicle Cambridge Marquity Investments Ltd with Martlet and Saranac Partners. Group will invest GBP100,000 into vehicle for 40% stake.

Current stock price: 115.30 pence

Year-to-date change: up sharply from 46.50p

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
25 Feb 2019 16:42

Invesco Divests Entire NetScientific Holding From 19% (ALLISS)

LONDON (Alliance News) - NetScientific PLC said Monday that Invesco Ltd divested its entire stake in the company.In a deal concluded on Friday, Invesco sold its 19.74% interest in the down

Read more
21 Feb 2019 18:08

NetScientific Shareholder Increases Interest To 30% After Transaction (ALLISS)

LONDON (Alliance News) - NetScientific PLC said on Thursday that shareholder M A Lawson has increased the holding in the company to 30% from 9.7%.Shares in the healthcare technology company

Read more
18 Feb 2019 17:46

JO Hambro Capital Management Sells Entire Holding In NetScientific (ALLISS)

LONDON (Alliance News) - NetScientific PLC on Monday said JO Hambro Capital Management Ltd no longer has a stake in the medical technology manufacturer after a transaction on Friday last to that,

Read more
15 Feb 2019 12:36

NetScientific Plans To Leave AIM Market After Failing To Agree Sales (ALLISS)

LONDON (Alliance News) - Shares in NetScientific PLC on Friday said it will be leaving the London Stock Exchange following a failure to find a buyer.The stock was down 59% on Friday at 3.30

Read more
15 Jan 2019 11:56

NetScientific Shares Plunge On Lack Of Takeover Approaches

LONDON (Alliance News) - Shares in NetScientific PLC slumped on Tuesday as it terminated its formal sales process, with no approaches made for its acquisition.Shares in NetScientific fell a

Read more
20 Dec 2018 15:02

No suitors for NetScientific as it suggests delisting

(Sharecast News) - Healthcare intellectual property commercialisation group NetScientific updated the market on its strategic review on Thursday, which it announced in late November.

Read more
26 Nov 2018 16:54

Netscientific Investee Mergers With Nasdaq-Listed Edge Therapeutics

LONDON (Alliance News) - Netscientific PLC said Monday investee PDS Biotechnology Corp has agreed to a merger with Nasdaq-listed Edge Therapeutics Inc, as the company also conducts a strategic the

Read more
1 Nov 2018 13:41

NetScientific Portfolio Firm Vortex Inks Manufacturing Agreement

LONDON (Alliance News) - NetScientific PLC said Thursday that its 66%-owned US-based portfolio company, Vortex BioSciences, has entered into a global manufacturing agreement with Stratec GmbH to a

Read more
28 Sep 2018 15:41

NetScientific Interim Revenue Down But Loss Narrows On Lower Expenses

LONDON (Alliance News) - NetScientific PLC on Friday said its loss narrowed in the first half of 2018 following a decline in operating costs.The healthcare investment company said its loss

Read more
20 Sep 2018 13:47

Netscientific Portfolio Firm ProAxsis Selected For Respiratory Study

LONDON (Alliance News) - Netscientific PLC said Thursday said ProAxsis Ltd, a company in its portfolio, had two products selected for inclusion in an upcoming medical trial funded by the European

Read more
15 Aug 2018 14:43

NetScientific's Wanda launches 'CareLink' digital health product

(Sharecast News) - Transatlantic healthcare IP commercialisation group NetScientific announced on Wednesday that portfolio company Wanda, which it said uses machine learning to help healthcare providers better manage the risk and care of patients, has launched its new digital health application 'Wanda CareLink'.

Read more
15 Aug 2018 11:10

NetScientific Investee Launches Wanda CareLink Mobile Application

LONDON (Alliance News) - NetScientific PLC on Wednesday said its portfolio company Wanda launched its new digital health application Wanda CareLink.The investment company said Wanda uses to

Read more
2 Aug 2018 13:23

NetScientific Portfolio Firm ProAxsis Gains CE Mark For Immunoassay

LONDON (Alliance News) - NetScientific PLC said Thursday its portfolio company ProAxsis Ltd has successfully registered a CE Mark for its third respiratory immunoassay.The CE Mark has been

Read more
1 Jun 2018 10:51

NetScientific Investee Gets Grant From Invest Northern Ireland

LONDON (Alliance News) - NetScientific PLC on Friday said portfolio firm ProAxsis has been awarded a grant in Northern Ireland to develop its protease biomarker technology.The unspecified a

Read more
21 May 2018 11:59

NetScientific Shares Rise As Wanda Reduces Patient Re-Admissions

LONDON (Alliance News) - Shares rose in NetScientific PLC on Monday as it said that majority-owned Wanda Inc reported a 46% reduction in re-admissions to hospitals of high-risk congestive heart in

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.